Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma: a Single-arm, Multicenter, Phase II Clinical Study.

This document provides information about a clinical trial, NCT06478264, that is currently being conducted to evaluate the effectiveness and safety of a treatment for small cell carcinoma of the esophagus. The trial involves the use of a drug called Adebrelimab, along with chemotherapy drugs Cisplatin and Carboplatin, and radiotherapy. The trial is not yet recruiting participants and aims to enroll 40 individuals between the ages of 18 and 75. The document includes contact information for the primary investigator and lists the eligibility criteria for participation in the trial. [Extracted from the article]